Incidental Uptake in Benign Gynecomastia on 68Ga-DOTATATE PET/CT

A 54-year-old man with mesenteric carcinoid tumor metastatic to the liver completed staging 68Ga-DOTATATE PET/CT demonstrating uptake in multiple hepatic lesions consistent with liver metastases with additional asymmetric increased uptake in the right greater than the left breast. Subsequent bilateral diagnostic mammogram revealed benign right greater than left gynecomastia without suspicious underlying mass. With Food and Drug Administration approval of 68Ga-DOTATATE and the increased use of this analog in neuroendocrine tumor imaging, this case illustrates a relevant example of uptake that can potentially mimic malignancy.
Source: Clinical Nuclear Medicine - Category: Nuclear Medicine Tags: Interesting Images Source Type: research

Related Links:

Authors: Saito M, Asanuma K, Hatta W, Koike T, Hata T, Fujishima F, Furukawa T, Unno M, Masamune A Abstract A 38-year-old Japanese man who had been diagnosed with appendiceal carcinoid and undergone ileocecal resection 8 years before, presented with duodenal obstruction caused by a submucosal tumor-like appearance. He was diagnosed with long-term recurrence of appendiceal goblet cell carcinoid (GCC) with a multi-morphological pattern based on the histological assessment of a duodenal biopsy and his previously resected appendix. He underwent subtotal stomach-preserving pancreaticoduodenectomy combined with resection...
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
Authors: Pramono LA Abstract The year of 2020 teaches us to prevent is always better than to cure. It is an old phrase that is being used for decades, but it is never been implemented cordially by our society nowadays. Covid-19 is a good lesson that reminds us to carefully prevent the spread of coronavirus which is now a pandemic worldwide. People now wash their hands more often and clean, wear a mask everywhere - everytime, do physical distancing, do healthy lifestyle such as physical activity, healthy diet, and consume multivitamins. They obey the cough and sneeze etiquette. Prevention awareness is never been suc...
Source: Acta medica Indonesiana - Category: Internal Medicine Tags: Acta Med Indones Source Type: research
Update to long-running study finds screening from age of 40 rather than 50 could save livesScreening women from the age of 40 for breast cancer has the potential to save lives, according to a study that will reopen the debate over the timing as well as the risks andbenefits of routine mammograms.A group at Queen Mary University of London looked at data on 160,000 women between the ages of 39 and 41 who were randomly assigned either to annual breast screening or to wait until they were eligible for the usual NHS screening, offered every three years from the age of 50.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Breast cancer Health Society Medical research Science Source Type: news
We present the case of a 52-year-old man with mediastinal atypical carcinoid (grade II) neuroendocrine tumor showing mild somatostatin receptor expression and intense FDG avidity with progressive disease on chemotherapy. Chemokine receptor targeted PET/CT with CXCR4 (68Ga-CXCR4) showed tracer avidity in tumor sites higher than the physiological sites, which may pave the way for CXCR4-targeted radionuclide therapy in this subgroup of patients.
Source: Clinical Nuclear Medicine - Category: Nuclear Medicine Tags: Interesting Images Source Type: research
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Oncology, Radiology, Preventive Medicine, News, Source Type: news
CONCLUSION: Self-reported health service usage after mammographic screening is higher in women who have been notified they have dense breasts. SO WHAT?: There is growing pressure for screening programs in Australia and internationally to routinely measure and report breast density to participants. Results from this study can inform screening programs of the likely impact of breast density notification on health service usage. While more information is needed to fill knowledge gaps in recommended action for women with dense breasts, the greatest risks to women arise from not being screened. Hence, health promotion practitio...
Source: Health Promotion Journal of Australia - Category: International Medicine & Public Health Tags: Health Promot J Austr Source Type: research
Publication date: Available online 7 August 2020Source: Journal of the American College of RadiologyAuthor(s): Garth H. Rauscher, Katherine Tossas-Milligan, Teresita Macarol, Paula M. Grabler, Anne Marie Murphy
Source: Journal of the American College of Radiology - Category: Radiology Source Type: research
“Young women,” defined as women younger than 40 years at breast cancer diagnosis, represent approximately 7% of all women diagnosed with breast cancer in developed countries. Breast cancer is the leading cause of cancer-related death in young women. It constitutes more than 12,150 newly diagnosed patients every year in the United States. Young women have specific issues including those related to fertility, cancer genetics, and psychosocial concerns, and often need a different approach than do older women.1 Although breast cancer in older women is detected most commonly by mammographic screening, breast cancer ...
Source: Contemporary Diagnostic Radiology - Category: Radiology Tags: ARTICLE Source Type: research
Publication date: Available online 12 August 2020Source: European Journal of RadiologyAuthor(s): Ioannis Sechopoulos, John M. Boone, David Dance, Ruben van Engen, Paolo Russo, Kenneth C. Young
Source: European Journal of Radiology - Category: Radiology Source Type: research
Publication date: Available online 8 August 2020Source: Academic RadiologyAuthor(s): Jessica H. Porembka, Lindsay Compton, Susan Schmidt, Dogan Polat, Yin Xi, Venetia Sarode, Basak E. Dogan
Source: Academic Radiology - Category: Radiology Source Type: research
More News: Brain | Cancer & Oncology | Carcinoid Tumor | Food and Drug Administration (FDA) | Gynecomastia | Liver | Mammography | Neurology | Nuclear Medicine | Urology & Nephrology